artios header image

News & Events

Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies

7 April 2021 | Press release

Artios Pharma to Attend Upcoming Conferences in February and March 2021

18 February 2021 | Press release

Niall Martin, Chief Executive Officer presented a company overview at LifeSci Partners Precision Oncology Day

17 February 2021 | Conferences

lifesci

Dr Graeme Smith presents at Medicine at The Crick – 11 February 2021

11 February 2021 | Conferences

tfci-1-400×400

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

11 February 2021 | Press release

image1-400×400

Medicine at The Crick – Thursday 11 February. Dr Graeme Smith is giving a talk.

5 February 2021 | Announcement

tfci-1-400×400

Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer

12 January 2021 | Press release

abid2

Graeme Smith (CSO), Helen Robinson (Head of Biology), Simon Boulton (VP Science Strategy) are speaking at the PARP & DDR Inhibitors Summit Digital January 26-28 2021

18 December 2020 | Conferences

21-summit-400×400

Artios shaking up the Biotech scene in Cambridge Top 15 !

16 December 2020 | Media coverage

Circus-plot-1-300×300

Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

3 December 2020 | Press release

merck

« Previous 1 2 3 4 5 6 Next »

© Artios Pharma 2023 | Website by Granite 5

Terms & conditions | Privacy policy | Site map